nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—GABRA3—Graves' disease	0.652	1	CbGaD
Meprobamate—CYP2E1—Methimazole—Graves' disease	0.144	0.615	CbGbCtD
Meprobamate—CYP2C19—Methimazole—Graves' disease	0.0903	0.385	CbGbCtD
Meprobamate—Aplastic anaemia—Methimazole—Graves' disease	0.00447	0.0836	CcSEcCtD
Meprobamate—Lymphadenopathy—Methimazole—Graves' disease	0.00405	0.0758	CcSEcCtD
Meprobamate—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0038	0.0711	CcSEcCtD
Meprobamate—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00358	0.0598	CbGpPWpGaD
Meprobamate—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00354	0.0591	CbGpPWpGaD
Meprobamate—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00344	0.0644	CcSEcCtD
Meprobamate—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00314	0.0525	CbGpPWpGaD
Meprobamate—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00311	0.0583	CcSEcCtD
Meprobamate—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00303	0.0506	CbGpPWpGaD
Meprobamate—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00301	0.0503	CbGpPWpGaD
Meprobamate—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00296	0.0494	CbGpPWpGaD
Meprobamate—Drowsiness—Methimazole—Graves' disease	0.00266	0.0498	CcSEcCtD
Meprobamate—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00259	0.0432	CbGpPWpGaD
Meprobamate—Agranulocytosis—Methimazole—Graves' disease	0.00248	0.0465	CcSEcCtD
Meprobamate—Drowsiness—Propylthiouracil—Graves' disease	0.00226	0.0424	CcSEcCtD
Meprobamate—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00219	0.0366	CbGpPWpGaD
Meprobamate—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00217	0.0362	CbGpPWpGaD
Meprobamate—Agranulocytosis—Propylthiouracil—Graves' disease	0.00211	0.0395	CcSEcCtD
Meprobamate—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00192	0.0321	CbGpPWpGaD
Meprobamate—Vertigo—Methimazole—Graves' disease	0.00187	0.035	CcSEcCtD
Meprobamate—Leukopenia—Methimazole—Graves' disease	0.00186	0.0349	CcSEcCtD
Meprobamate—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00186	0.031	CbGpPWpGaD
Meprobamate—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00184	0.0308	CbGpPWpGaD
Meprobamate—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00181	0.0303	CbGpPWpGaD
Meprobamate—Vertigo—Propylthiouracil—Graves' disease	0.00159	0.0297	CcSEcCtD
Meprobamate—Leukopenia—Propylthiouracil—Graves' disease	0.00158	0.0296	CcSEcCtD
Meprobamate—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00158	0.0264	CbGpPWpGaD
Meprobamate—Paraesthesia—Methimazole—Graves' disease	0.00152	0.0285	CcSEcCtD
Meprobamate—Somnolence—Methimazole—Graves' disease	0.00151	0.0283	CcSEcCtD
Meprobamate—Body temperature increased—Methimazole—Graves' disease	0.00134	0.0251	CcSEcCtD
Meprobamate—Paraesthesia—Propylthiouracil—Graves' disease	0.0013	0.0243	CcSEcCtD
Meprobamate—Somnolence—Propylthiouracil—Graves' disease	0.00128	0.024	CcSEcCtD
Meprobamate—Pruritus—Methimazole—Graves' disease	0.0012	0.0225	CcSEcCtD
Meprobamate—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.00116	0.0194	CbGpPWpGaD
Meprobamate—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.00115	0.0192	CbGpPWpGaD
Meprobamate—Body temperature increased—Propylthiouracil—Graves' disease	0.00114	0.0214	CcSEcCtD
Meprobamate—Vomiting—Methimazole—Graves' disease	0.00108	0.0202	CcSEcCtD
Meprobamate—Dermatitis—Methimazole—Graves' disease	0.00107	0.02	CcSEcCtD
Meprobamate—Headache—Methimazole—Graves' disease	0.00106	0.0199	CcSEcCtD
Meprobamate—Pruritus—Propylthiouracil—Graves' disease	0.00102	0.0191	CcSEcCtD
Meprobamate—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00102	0.017	CbGpPWpGaD
Meprobamate—Nausea—Methimazole—Graves' disease	0.00101	0.0189	CcSEcCtD
Meprobamate—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.000985	0.0165	CbGpPWpGaD
Meprobamate—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000979	0.0163	CbGpPWpGaD
Meprobamate—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000961	0.0161	CbGpPWpGaD
Meprobamate—Vomiting—Propylthiouracil—Graves' disease	0.000918	0.0172	CcSEcCtD
Meprobamate—Dermatitis—Propylthiouracil—Graves' disease	0.000909	0.017	CcSEcCtD
Meprobamate—Headache—Propylthiouracil—Graves' disease	0.000904	0.0169	CcSEcCtD
Meprobamate—Nausea—Propylthiouracil—Graves' disease	0.000857	0.0161	CcSEcCtD
Meprobamate—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.00084	0.014	CbGpPWpGaD
Meprobamate—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000678	0.0113	CbGpPWpGaD
Meprobamate—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.00067	0.0112	CbGpPWpGaD
Meprobamate—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000595	0.00994	CbGpPWpGaD
Meprobamate—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000574	0.00959	CbGpPWpGaD
Meprobamate—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000571	0.00953	CbGpPWpGaD
Meprobamate—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.00056	0.00936	CbGpPWpGaD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000535	0.00893	CbGpPWpGaD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000528	0.00882	CbGpPWpGaD
Meprobamate—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.00049	0.00818	CbGpPWpGaD
Meprobamate—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000476	0.00795	CbGpPWpGaD
Meprobamate—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.00047	0.00785	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000469	0.00784	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000453	0.00756	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00045	0.00751	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000442	0.00738	CbGpPWpGaD
Meprobamate—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000418	0.00697	CbGpPWpGaD
Meprobamate—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000403	0.00673	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000402	0.00672	CbGpPWpGaD
Meprobamate—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.0004	0.00669	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000397	0.00663	CbGpPWpGaD
Meprobamate—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000393	0.00657	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000386	0.00645	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000353	0.00589	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000344	0.00574	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00034	0.00569	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000338	0.00565	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000332	0.00555	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000308	0.00515	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000304	0.00508	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00029	0.00485	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—GABRA3—Graves' disease	0.00027	0.00451	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000261	0.00436	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000259	0.00433	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000254	0.00425	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000222	0.00372	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000166	0.00277	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000164	0.00273	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000153	0.00255	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CD40—Graves' disease	0.00015	0.0025	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000147	0.00246	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000145	0.00243	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00014	0.00234	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000139	0.00233	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000137	0.00229	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000121	0.00203	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00012	0.002	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000109	0.00182	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000107	0.00178	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000103	0.00172	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000102	0.00171	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000101	0.00169	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	9.23e-05	0.00154	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.95e-05	0.00116	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.95e-05	0.00116	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IFNG—Graves' disease	6.74e-05	0.00113	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL1B—Graves' disease	6.01e-05	0.001	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	6e-05	0.001	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	5.26e-05	0.000878	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	5.07e-05	0.000847	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	5.04e-05	0.000843	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—TNF—Graves' disease	4.36e-05	0.000728	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GC—Graves' disease	4.01e-05	0.00067	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GC—Graves' disease	3.1e-05	0.000517	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—B3GNT2—Graves' disease	3.04e-05	0.000508	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GC—Graves' disease	3.02e-05	0.000505	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.35e-05	0.000392	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—B3GNT2—Graves' disease	2.29e-05	0.000383	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	2.15e-05	0.000359	CbGpPWpGaD
